Moderna MRNA
NASDAQ MRNA
$218.00 -18.50 (-7.82%)
As of: Oct 16, 2026 · 3:59 PM EDT

Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2026)

Updated

Moderna's Net Equity Issued and Repurchased came in at $23 million for Q2 2026, up 64.3% from $14 million a year earlier and up 21.1% from the prior quarter.

Analysis

Moderna (MRNA) Net Equity Issued and Repurchased (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Moderna reported Net Equity Issued and Repurchased of $60 million, up 66.7% year-over-year; for FY2025, it came in at $35 million, down 47.0% from FY2024.

  • Net Equity Issued and Repurchased carries a five-year compound annual growth rate of -54.8% (FY2020 to FY2025).
  • Going back by year, Net Equity Issued and Repurchased was $66 million in FY2024 (+43.5%), $46 million in FY2023 (-29.2%), $65 million in FY2022 (-47.6%) and $124 million in FY2021 (-93.3%).
  • The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased since Q2 2024.
  • Year-over-year, Net Equity Issued and Repurchased has increased for three consecutive quarters, with growth averaging 54.8% over the last eight quarters.
  • The fastest year-over-year change in Net Equity Issued and Repurchased over five years came in Q1 2026 (growth of 533.3%), and the weakest in Q1 2025 (a decline of 80.0%).
  • Business Quant data shows MRNA's Net Equity Issued and Repurchased at $19 million (Q1 2026), $16 million (Q4 2025) and $2 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Eli Lilly 1,122.91 Bn 1,091.50 Bn 19.71 Bn -1.60 Bn
2 Johnson & Johnson 615.09 Bn 533.62 Bn 17.26 Bn 138.00 Mn
3 AbbVie 504.75 Bn 477.86 Bn 12.70 Bn -9.00 Mn
4 Merck 360.18 Bn 314.55 Bn 12.21 Bn -714.00 Mn
5 Novartis Ag 292.05 Bn 256.04 Bn 11.24 Bn -1.20 Bn
6 Astrazeneca 256.09 Bn 229.78 Bn 12.86 Bn 6.00 Mn
7 Amgen 233.63 Bn 189.02 Bn 7.24 Bn -
8 Gilead Sciences 194.49 Bn 168.69 Bn 6.22 Bn -346.00 Mn
9 Pfizer 168.35 Bn 114.99 Bn 10.94 Bn -
10 Moderna 85.93 Bn 65.29 Bn 52.00 Mn 23.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 23.00 Mn
Mar 31, 2026 19.00 Mn
Dec 31, 2025 16.00 Mn
Sep 30, 2025 2.00 Mn
Jun 30, 2025 14.00 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 11.00 Mn
Sep 30, 2024 8.00 Mn
Jun 30, 2024 32.00 Mn
Mar 31, 2024 15.00 Mn
Dec 31, 2023 15.00 Mn
Sep 30, 2023 7.00 Mn
Jun 30, 2023 -612.00 Mn
Mar 31, 2023 -517.00 Mn
Dec 31, 2022 -377.00 Mn
Sep 30, 2022 -995.00 Mn
Jun 30, 2022 -1.28 Bn
Mar 31, 2022 -611.00 Mn
Dec 31, 2021 -829.00 Mn
Sep 30, 2021 32.00 Mn
API Access

Moderna Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=MRNA&period=max&api_key=YOUR_API_KEY